American Heart Association

http://www.heart.org/

US Food and Drug Administration

http://www.fda.gov/

Health Canada

http://www.hc-sc.gc.ca/index_e.html/

Heart and Stroke Foundation of Canada

http://ww2.heartandstroke.ca/splash/

Amarenco P, Bogousslavsky J, Callahan A III, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549-59.

DynaMed Editorial Team. Statins. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what.php. Updated November 24, 2010. Accessed December 9, 2010.

Grundy SM, Cleeman JL, Merz CN et al. National Heart, Lung, and Blood Institute, American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Eudcation Program Adult Treatment Panel III (NCEP ATP III) guidelines. Circulation. 2004;110:227-239.

HMG-CoA reductase inhibitors (systemic). US Pharmacopeia (USP-DI). Available at: http://www.usp.org. Accessed on January 28, 2003.

Keeping cholesterol under control. US Food and Drug Administration website. Available at: http://www.fda.gov/fdac/features/1999/199_chol.html. Accessed on January 28, 2003.

Lemaitre RN, Psaty B, Heckbert SR, et al. Therapy with hydroxymethylglutaryl coenzyme A reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults. Arch Intern Med. 2002;162:1395-1400.

Middleton A, Binbrek AS, Fonseca FA, et al. Achieving 2003 European lipid goals with rosuvastatin and comparator statins in 6743 patients in real-life clinical practice: DISCOVERY meta-analysis. Curr Med Res Opin. 2006;22: 1181-91.

Stender S, Schuster H, Barter P, et al. Comparison of rosuvastatin with atorvastatin, simvastatin, and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial. Diabetes Obes Metab. 2005;7:430-8.

Tahara N, Kai H, Ishibashi M, et al. Simvastatin attenuates plaque inflammation: evaluation by fuorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 2006;48:1825-31.

Texas Heart Institute. Available at: http://www.tmc.edu/thi/. Accessed on January 28, 2003.

1/30/2009 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed/what.php: Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients. J Am Coll Cardiol. 2008;52:1769-1781.